S1 Table: Detailed histopathological results of false-negative ... - PLOS

S1 Table: Detailed histopathological results of false-negative and false-positive lesions Imaging modality T2w1 DWI2

False positives 3 Prostatitis 4 BPH6 4 Prostatitis 5 BPH

n 7 9

7 3 BPH

Single parameter

3 BPH

6 BPH 5

5

4

3 Prostatitis

9

1 GS 6 (3+3) 1 GS 8 (4+4)

2

5 GS 7 (4+3)

14

4 GS 6 (3+3)

2 BPH

T2w and PET

4 GS 7 (4+3

1 GS 8 (4+4)

2 Prostatits T2w and DCE

9

8 GS 6 (3+3)

3 BPH Two parameters

3 GS 7 (4+3

1 GS 8 (4+4)

2 Prostatitis T2w and 1H-MRSI

14

4 GS 6 (3+3) 11

3 Prostatitis 2 BPH

5 GS 7 (4+3)

1 GS 8 (4+4)

5 Prostatitis

T2w and DWI

2

5 GS 6 (3+3) 7

PET5

2

1 GS 8 (4+4)

4 Prostatitis DCE4

n

8 GS 6 (3+3)

4 Prostatitis 3D 1H-MRSI3

False negatives 1 GS 6 (3+3) 1 GS 8 (4+4) 1 GS 6 (3+3) 1 GS 8 (4+4)

4 GS 7 (4+3)

9

1 GS 8 (4+4) 5

6 GS 6 (3+3) 4 GS 7 (4+3)

11

2 BPH T2w, DWI and 1HMRSI Three parameters

T2w, DWI and DCE T2w, DWI and PET T2w, DWI, 1HMRSI and DCE

Four parameters

T2w, DWI, 1HMRSI and PET T2w, DWI, DCE and PET

MP [11C]Acetate PET-MRI

1

T2w, DWI, HMRSI, DCE and PET

3 Prostatitis 3 BPH 3 Prostatitis 4 BPH 4 Prostatitis 5 BPH 3 Prostatitis 4 BPH 4 Prostatitis 4 BPH 3 Prostatitis 4 BPH

1 GS 8 (4+4) 6 7 9 7 8 7

7

1

T2-weighted MRI

2

diffusion-weighted imaging

3

three-dimensional proton MR spectroscopic imaging

4

dynamic contrast-enhanced MRI

5

positron emission tomography

6

benign prostatic hyperplasia

2 2 2 2 2 2

2 GS 6 (3+3)

3 Prostatitis

4 BPH

1 GS 6 (3+3) 1 GS 8 (4+4) 1 GS 6 (3+3) 1 GS 8 (4+4) 1 GS 6 (3+3) 1 GS 8 (4+4) 1 GS 6 (3+3) 1 GS 8 (4+4) 1 GS 6 (3+3) 1 GS 8 (4+4) 1 GS 6 (3+3) 1 GS 8 (4+4)

1 GS 7 (4+3) 1 GS 8 (4+4)

4